NIH’s changes in grant review criteria aim to refocus grant evaluation back on the science. But how long will the hangover of the old ways last? And what will be the unintended consequences from this streamlined approach?
NIH’s changes in grant review criteria aim to refocus grant evaluation back on the science. But how long will the hangover of the old ways last? And what will be the unintended consequences from this streamlined approach?